Communiqués ADMA Biologics, Inc.

Actions

ADMA

US0008991046

Produits pharmaceutiques

Marché Fermé - Nasdaq 22:00:00 02/10/2026			Varia. 5j.	Varia. 1 janv.
9,720 ^USD	-2,11%		+3,62%	-46,71%

06/08	Transcript : ADMA Biologics, Inc., Q2 2026 Earnings Call, Aug 05, 2026
05/08	Flash résultats (ADMA) : ADMA Biologics, Inc. publie un chiffre d'affaires de 124,4 millions de dollars au deuxième trimestre, contre une estimation FactSet de 125,3 millions de dollars	MT

Communiqués

14/09	Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (ADMA)	NE
24/08	Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (ADMA)	NE
12/08	Berger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (ADMA)	NE
08/08	ADMA Biologics 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA	BU
07/08	ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
07/08	MONDAY DEADLINE: Berger Montague Advises ADMA Biologics, Inc. (ADMA) Investors to Inquire About a Securities Fraud Class Action by August 10, 2026	NE
06/08	CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises ADMA Biologics, Inc. (ADMA) Investors to Inquire About a Securities Fraud Class Action by August 10, 2026	NE
05/08	Adma Biologics: Q2 Earnings Snapshot	AQ
05/08	ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update	GL
05/08	ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update	AQ
03/08	ADMA Holzer & Holzer, LLC Reminds Investors of the August 10, 2026 Lead Plaintiff Deadline ADMA Biologics, Inc. Securities Class Action	NE
03/08	ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
31/07	ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
29/07	ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
29/07	ADMA BIOLOGICS, INC. (ADMA) Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action	NE
29/07	ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026	GL
29/07	ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026	AQ
27/07	ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
24/07	ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
23/07	CLASS ACTION REMINDER: Berger Montague Advises ADMA Biologics, Inc. (ADMA) Investors to Inquire About a Securities Fraud Lawsuit by August 10, 2026	NE
22/07	ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
21/07	ADMA UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026	NE
20/07	ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline	NE
20/07	ADMA CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026	NE
17/07	ADMA DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026	NE